Advertisement
Research Article Free access | 10.1172/JCI116661
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Find articles by Matsumura, K. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Find articles by Tomé, F. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Find articles by Ionasescu, V. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Find articles by Ervasti, J. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Find articles by Anderson, R. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Find articles by Romero, N. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Find articles by Simon, D. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Find articles by Récan, D. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Find articles by Kaplan, J. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Find articles by Fardeau, M. in: JCI | PubMed | Google Scholar
Published August 1, 1993 - More info
Dystrophin, the protein product of the Duchenne muscular dystrophy (DMD) gene, is a cytoskeletal protein tightly associated with a large oligomeric complex of sarcolemmal glycoproteins including dystroglycan, which provides a linkage to the extracellular matrix component, laminin. In DMD, the absence of dystrophin leads to a drastic reduction in all of the dystrophin-associated proteins, causing the disruption of the linkage between the subsarcolemmal cytoskeleton and the extracellular matrix which, in turn, may render muscle cells susceptible to necrosis. The COOH-terminal domains (cysteine-rich and carboxyl-terminal) of dystrophin have been suggested to interact with the sarcolemmal glycoprotein complex. However, truncated dystrophin lacking these domains was reported to be localized to the sarcolemma in four DMD patients recently. Here we report that all of the dystrophin-associated proteins are drastically reduced in the sarcolemma of three DMD patients in whom dystrophin lacking the COOH-terminal domains was properly localized to the sarcolemma. Our results indicate that the COOH-terminal domains of dystrophin are required for the proper interaction of dystrophin with the dystrophin-associated proteins and also support our hypothesis that the loss of the dystrophin-associated proteins in the sarcolemma leads to severe muscular dystrophy even when truncated dystrophin is present in the subsarcolemmal cytoskeleton.
Images.